Related Experiment Video
Updated: Jun 15, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Positron emission tomography in schizophrenia: a new perspective
Neva H Patel1, Nora S Vyas, Basant K Puri
1Radiological Sciences Unit, Imperial College Healthcare NHS Trust, London, United Kingdom. Neva.Patel@imperial.nhs.uk
Summary
Positron Emission Tomography (PET) reveals brain abnormalities in schizophrenia. Key findings include altered dopamine levels and D2 receptor density, particularly in the prefrontal cortex and striatum.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Positron Emission Tomography (PET) is a functional imaging technique crucial for studying neurotransmitter systems in the human brain.
- PET is increasingly vital for advancing the understanding of schizophrenia's neurobiology and pathophysiology.
Purpose of the Study:
- This review examines the application of PET tracers and kinetic modeling in schizophrenia research.
- The study aims to identify regional brain abnormalities and cognitive function correlates in schizophrenia using PET.
Main Methods:
- Utilizes various PET tracers, including (11)C, (15)O-water, (18)F-fallypride, and L-3,4-dihydroxy-6-(18)F-fluorophenylalanine ((18)F-FDOPA).
- Employs kinetic modeling, including compartmental modeling, to analyze tracer binding kinetics and regional brain function.
Main Results:
- Consistent differences in dopamine content observed in the prefrontal cortex, anterior cingulate gyrus, and hippocampus between healthy individuals and schizophrenia patients.
- Findings indicate higher D(2) receptor density in the striatum and evidence of neural brain dysconnectivity in schizophrenia.
Conclusions:
- Further research integrating clinical, imaging, genetic, and cognitive data is essential.
- Comprehensive approaches are needed to fully elucidate the pathophysiology of schizophrenia.
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:30Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.